a public good project by the
Synthesis
Company
of California

© 2026

Hisaaki Miyahara | doi.page

0 works0 citations0 h-index

Hisaaki Miyahara

National Kyushu Medical Center(JP)

Publications by Year

Research Areas

Rheumatoid Arthritis Research and Therapies, Cell Adhesion Molecules Research, Total Knee Arthroplasty Outcomes, Autoimmune and Inflammatory Disorders Research, Orthopaedic implants and arthroplasty

Most-Cited Works

→ The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon‐γ and interleukin‐17 production by human CD4+ T cells(2011)227 cited
→ Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study(2013)119 cited
→ LIMB ALLOGRAFTS IN RATS IMMUNOSUPPRESSED WITH FK506(1989)90 cited
→ Effect of IL-10 on collagen-induced arthritis in mice(1996)86 cited
→ Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study(2014)72 cited
→ INDUCTION OF CHRONIC AUTOIMMUNE ARTHRITIS IN DBA/1 MICE BY ORAL ADMINISTRATION OF TYPE II COLLAGEN AND ESCHERICHIA COLl LIPOPOLYSACCHARIDE(1996)52 cited

→ Mannose binding lectin (MBL) gene mutation is not a risk factor for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) in Japanese(2000)

49 cited

→ Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study(2015)47 cited

→ Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate(2010)46 cited

→ Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study(2012)46 cited